IMRT Improves Survival in Locally Advanced NSCLC (LA-NSCLC) Receiving Definitive Radiotherapy: A Population Based Time-Trend Analysis

被引：0
|
作者：
Wang, Jingbo [1 ]
Cao, Jianzhong [2 ]
Ji, Zhe [2 ]
Liu, Lipin [2 ]
Jiang, Wei [2 ]
Men, Yu [2 ]
Xu, Cai [2 ]
Wang, Luhua [1 ]
机构：
[1] Chinese Acad Med Sci, Canc Hosp, Radiat Oncol, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
intensity modulated radiotherapy; time-trend analysis; survival; non small cell lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.03-020
引用
收藏
页码：S448 / S449
页数：2
相关论文
共 50 条
  • [21] Obesity Is Associated with Long-Term Improved Survival in Definitively Treated Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)
    Lam, Vincent K.
    Bentzen, Soren M.
    Mohindra, Pranshu
    Nichols, Elizabeth M.
    Bhooshan, Neha
    Vyfhuis, Melissa
    Feigenberg, Steven J.
    Edelman, Martin
    Feliciano, Josephine L.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S451 - S451
  • [22] 4D-PET/CT-BASED ADAPTIVE DOSE ESCALATED RADIOTHERAPY (RT) IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (LA-NSCLC)
    Yap, Mei Ling
    Sun, Alexander
    Marshall, Andrea
    Becker, Nathan
    Higgins, Jane
    Le, Lisa
    Vines, Douglass
    Clarke, Katy
    Bezjak, Andrea
    Bissonnette, Jean-Pierre
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S835 - S835
  • [23] Time-Trend Analysis In Pancreatic Cancer Survival - Results From A Population-Based Study
    Khosla, Manraj S.
    Wani, Sachin
    Das, Ananya
    GASTROENTEROLOGY, 2016, 150 (04) : S651 - S652
  • [24] Intensity modulated radiotherapy (IMRT) in locally advanced non small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): Analysis of survival and toxicity outcomes
    McCloskey, P.
    Robinson, H.
    Shrimali, R.
    Dearden, R.
    Whitehurst, P.
    Ashcroft, L.
    Bayman, N.
    Burt, P.
    Chittalia, A.
    Coote, J.
    Harris, M.
    Lee, L.
    Pemberton, L.
    Sheikh, H.
    Faivre-Finn, C.
    LUNG CANCER, 2013, 79 : S55 - S56
  • [25] Role of Whole-Heart Dose on Overall Survival (OS) in Locally-Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Patients (Pts) Treated with Concurrent Definitive Chemoradiotherapy (CDCRT)
    Dilling, T. J.
    Allen, A.
    Edrich, O.
    Dudas, D.
    Money, D.
    Eichelberger, G.
    Kumar, A.
    Bryant, J. M.
    Cruz-Chamorro, R. J.
    El Naga, I.
    Keit, E.
    Feygelman, V.
    Lee, D. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E16 - E16
  • [26] Predictive Factors for Mediastinal Nodal Failure in Locally-advanced Non-small-cell Lung Cancer (NSCLC) Patients Receiving Definitive Radiotherapy (RT)
    Fernandes, A.
    Lin, L.
    Shen, J.
    Finlay, J.
    Evans, T.
    Langer, C.
    Stevenson, J.
    Glatstein, E.
    Hahn, S.
    Rengan, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S163 - S164
  • [27] Quality of life in poor prognosis patients with locally advanced non-small cell lung cancer (LA-NSCLC) undergoing a phase II study of concurrent cetuximab and definitive thoracic radiotherapy followed by docetaxel and cetuximab.
    Thompson, Lora
    Extermann, Martine
    Dilling, Thomas J.
    Kim, Jongphil
    Yue, Binglin
    Stevens, Craig William
    Antonia, Scott
    Gray, Jhanelle Elaine
    Williams, Charles C.
    Haura, Eric B.
    Pinder, Mary Colleen
    Tanvetyanon, Tawee
    Chiappori, Alberto
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] INDIVIDUALISED ACCELERATED RADIOTHERAPY (INDAR) IMPROVES SURVIVAL OF PATIENTS WITH STAGE III NSCLC: A PROSPECTIVE POPULATION-BASED STUDY
    De Ruysscher, Dirk
    Steevens, Jessie
    Botterweck, Anita
    Reymen, Bart
    Van Baardwijk, Angela
    Wanders, Rinus
    Borger, Jacques
    Dingemans, Anne-Marie
    Bootsma, Gerben
    Pitz, Cordula
    Lunde, R.
    Geraedts, Wiel
    Lambin, Philippe
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S546 - S547
  • [29] A single centre's experience of toxicity, compliance and survival in patients with stage III locally advanced non-small cell lung cancer (LA-NSCLC) treated with concurrent chemo-radiotherapy (CCTRT)
    Hague, C.
    Ashcroft, L.
    Bayman, N.
    Blackhall, F.
    Burt, P. A.
    Coote, J. H.
    Fenemore, J.
    Harris, M. A.
    Lee, L. W.
    Pemberton, L.
    Sheikh, H. Y.
    Chittalia, A. Z.
    Taylor, P.
    Faivre-Finn, C.
    LUNG CANCER, 2015, 87 : S52 - S53
  • [30] Phase II study of concurrent cetuximab (C225) plus definitive thoracic radiotherapy (XRT) followed by adjuvant docetaxel in poor prognosis patients with locally advanced non-small cell lung cancer (LA-NSCLC).
    Dilling, Thomas J.
    Extermann, Martine
    Kim, Jongphil
    Thompson, Lora
    Yue, Binglin
    Stevens, Craig William
    Antonia, Scott
    Gray, Jhanelle Elaine
    Williams, Charles C.
    Haura, Eric B.
    Pinder, Mary Colleen
    Tanvetyanon, Tawee
    Chiappori, Alberto
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345